Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
69
Frequently Asked Questions
What is Market Cap of Rapport Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Rapport Therapeutics Inc. market cap is $955.88M.
What is the 52-week high for Rapport Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rapport Therapeutics Inc. 52 week high is $42.27 as of September 18, 2025.
What is the 52-week low for Rapport Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rapport Therapeutics Inc. 52 week low is $6.43 as of September 18, 2025.
What is Rapport Therapeutics Inc. stock price today?
Rapport Therapeutics Inc. stock price today is $26.30.
What was Rapport Therapeutics Inc. stock price yesterday?
Rapport Therapeutics Inc. stock price yesterday was $26.19.
What is the PE ratio of Rapport Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Rapport Therapeutics Inc.’s P/E ratio is -10.64.
What is the Price-to-Book ratio of Rapport Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Rapport Therapeutics Inc. P/B ratio is 3.6274.
What is the 50-day moving average of Rapport Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Rapport Therapeutics Inc. 50-day moving average is $16.51.
How many employess does Rapport Therapeutics Inc. has?